Melissa Maney

Melissa Maney is an experienced executive in strategic business development and patient services, currently serving as Vice President at Precision AQ since July 2023, where responsibilities include expanding partnerships for large pharmaceutical clients. Previously, at UBC, Melissa held the role of Executive Director for Patient Services Business Development, leading strategies for rare and gene therapies. Additional roles include Chief Commercial Lead at EVERSANA, focusing on go-to-market strategies during the COVID-19 pandemic, and various positions at Horizon Pharma plc and Lundbeck, where Melissa demonstrated expertise in sales, marketing, and operational management in rare disease sectors. Melissa's career began at UCB Pharma, where a foundation in managing and training teams was established. Melissa earned a Bachelor of Science in Business Management from Buffalo State University.